- Home
- CRIS vs CENN Comparison
CRIS vs CENN Comparison
Compare CRIS & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- CENN
- Stock Information
- Founded
- CRIS 2000
- CENN 2013
- Country
- CRIS United States
- CENN United States
- Employees
- CRIS N/A
- CENN N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- CENN Auto Manufacturing
- Sector
- CRIS Health Care
- CENN Consumer Discretionary
- Exchange
- CRIS Nasdaq
- CENN Nasdaq
- Market Cap
- CRIS 22.9M
- CENN 28.0M
- IPO Year
- CRIS 2000
- CENN N/A
- Fundamental
- Price
- CRIS $1.71
- CENN $0.56
- Analyst Decision
- CRIS Strong Buy
- CENN
- Analyst Count
- CRIS 2
- CENN 0
- Target Price
- CRIS $16.50
- CENN N/A
- AVG Volume (30 Days)
- CRIS 74.8K
- CENN 221.2K
- Earning Date
- CRIS 11-13-2025
- CENN 11-11-2025
- Dividend Yield
- CRIS N/A
- CENN N/A
- EPS Growth
- CRIS N/A
- CENN N/A
- EPS
- CRIS N/A
- CENN N/A
- Revenue
- CRIS $11,405,000.00
- CENN $30,189,622.00
- Revenue This Year
- CRIS $1.41
- CENN N/A
- Revenue Next Year
- CRIS $7.46
- CENN N/A
- P/E Ratio
- CRIS N/A
- CENN N/A
- Revenue Growth
- CRIS 12.24
- CENN 143.95
- 52 Week Low
- CRIS $1.02
- CENN $0.47
- 52 Week High
- CRIS $6.44
- CENN $1.47
- Technical
- Relative Strength Index (RSI)
- CRIS 50.12
- CENN 54.92
- Support Level
- CRIS $1.65
- CENN $0.52
- Resistance Level
- CRIS $1.95
- CENN $0.57
- Average True Range (ATR)
- CRIS 0.14
- CENN 0.02
- MACD
- CRIS 0.01
- CENN 0.01
- Stochastic Oscillator
- CRIS 35.29
- CENN 83.44
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.